SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
SHPHCIK 0001757499
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$11.26M
−28.2% YoY
Q1 May 2026
EPS Diluted (TTM)
−$12.37
+91.3% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$7.54M
Q1 May 2026
Cash
$1.09M
Q1 May 2026
Total Debt
$91.02K
Q1 May 2026
Shares Outstanding
5.85M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.